Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)

• Main Authors: A. Nassar-Sheikh Rashid (Author), D. Schonenberg-Meinema (Author), S. C. Bergkamp (Author), S. Bakhlakh (Author), A. de Vries (Author), T. Rispens (Author), T. W. Kuijpers (Author), G. Wolbink (Author), J. M. van den Berg (Author)
• Format: Book
• Published: BMC, 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Anti-tumor necrosis factor (TNF) drugs have improved the prognosis for juvenile idiopathic arthritis (JIA) significantly. However, evidence for individual treatment decisions based on serum anti-TNF drug levels and the presence of anti-drug antibodies (ADAbs) in children is scarc...